Introduction {#Sec1}
============

*Syringa oblata* Lindl, a medicinal plant which has the characteristics of trees or shrubs of the Oleaceae family, is native to north China. *S. oblate* tastes bitter, and has quality of cold. Chinese Materia Medica records that the leaves and bark of *S. oblata* have been used as folk medicine, which have heat-clearing, detoxifying, dampness -removing and jaundice-relieving effect \[[@CR1]\].

Many studies were reported on the chemical constituents of *S. oblate* in China. Zhang et al. \[[@CR2]--[@CR6]\] isolated more than 50 compounds from the twigs, bark, leaves, alabastrum, seeds, and seed crust of *S. oblate*. These compounds were identified as oleanolic acid, lupinic acid, lupeol, 4-hydroxyphenethyl alcohol, 3,4-dihydroxyphenylethanol, *p*-hydroxyphenylethanol acetate, 2-(3,4-dihydroxy) phenyl ethyl acetate, *p*-hydroxyphenylethyl propyl ester, (8E)-ligstroside, oleuropein, syringopicroside, lariciresinol and esculetin, respectively. Tian et al. \[[@CR7]\] isolated 9 compounds, including (+) pinoresinol-4″-*O*-*β*-[d]{.smallcaps}-glucopyranoside, (+)lariciresinol-4-*O*-*β*-[d]{.smallcaps}-glucoside, and epipinoresinol-4-*O*-*β*-[d]{.smallcaps}-glucopyranoside, from the leaves of *S. oblate*. Zhou \[[@CR8]\] reported 2-furancarboxylic, mannitol, cyclohexane-1,2,3,4,5,6- hexaol, succinic acid, *p*-hydroxyphenylethyl alcohol and formononetin isolated from the leaves of *S. oblate*. Yang et al. \[[@CR9]\] analyzed the compositions in the essential oil from fruits and leaves of *S. oblate*. Jiao et al. \[[@CR10]\] found that the main component of the dried flowers of *S. oblate* were the same as those in the fruits and leaves.

These references indicate that triterpenes, phenethyl alcohol, phenylpropanoid and iridoid compounds are the main components in *S. oblate*. However, the flavonoids, organic acids and other constituents have been less reported.

In view of the fact that the *S. oblate* has a wide range of biological activities, including antibacterial, anti-inflammatory, antiviral, anti-tussive and expectorant effect, liver protection and cholagogue etc. \[[@CR11]\]. The previous studies on *S. oblate* flowers were mainly focused on the volatile components and its traditional pharmacological activity. Thus, this study aimed to investigate the nonvolatile chemical constituents and the coagulation activity of *S. oblate* flowers.

Methods {#Sec2}
=======

Chemicals and material {#Sec3}
----------------------

The chemicals and material were similar to our previous research \[[@CR12]\].

Plant material {#Sec4}
--------------

*Syringa oblata* flowers were collected in April 2015 from the Kaifeng region of Henan Province, China and identified by Professor Changqin Li. A voucher specimen was deposited in National R & D Center for Edible Fungus Processing Technology, Henan University.

Animal {#Sec5}
------

The male rabbit (approximately 20 months old, weight from 2.0 to 2.5 kg) was provided by Kaifeng Key Laboratory of Functional Components in Health Food (2016-02) to evaluate anticoagulant effect in vitro.

Ethics information {#Sec6}
------------------

The study obtained ethical clearance from the Ethics Committee of College of Medical, Henan University (NO: 2016-36). The rabbits were treated as per the guidelines on the care and use of animals for scientific purposes.

Extraction and isolation {#Sec7}
------------------------

The extracted method was similar to our previous research \[[@CR12]\]. The air-dried flowers of *S. oblata* (1.4 kg) were extracted with 70% ethanol to yield the crude extract (So. TE 378 g). The extract (378 g) was dissolved in MeOH-H~2~O (v:v = 3:1, 500 mL), and then mixed with D101 macroporous adsorbent resin. TE was separated by macroporous resin column chromatography, eluted with 20%, 40%, 60%, and 90% ethanol. After evaporation of the solvent, 235 g of water part, 27 g of 20% ethanol part, 61 g of 40% ethanol part, 20 g of 60% ethanol part and 35 g of 90% ethanol part were obtained.

The 60% ethanol part was separated on a silica gel H column by medium pressure liquid chromatography (MPLC), eluted with dichloromethane-methanol (v:v = 1:0--2:1) to obtain 2 fractions (F~1~--F~2~) based on TLC analyses. F~1~ was separated on a silica gel H column by MPLC, eluted with dichloromethane-acetone (v:v = 1:0--0:1) and then separated by Sephadex LH-20 (methanol) to obtain compound **1** (3 mg). F~2~ was separated with Sephadex LH-20 (methanol) and Sephadex LH-20 (methanol/water, 3:1, v/v) to obtain compound **2** (18 mg).

40% ethanol part was separated on a silica gel H column by MPLC, eluted with dichloromethane-methanol (v:v = 50:1--1:1) to obtain 6 fractions (P~1~--P~7~) based on TLC analyses. P~1~ was separated with Sephadex LH-20 (dichloromethane/methanol, 1:1, v/v) and Sephadex LH-20 (methanol) to obtain P~1-a~ and P~1-b~. F~1-a~ was subjected to atmospheric pressure chromatographic column of silica gel H with CHCl~2~-acetone (v:v = 1:0--0:1) to obtain compound **3** (20 mg). Compound **4** (16 mg) was obtained by the same separation method from F~1-b~. P~2~ was subjected to ordinary pressure chromatographic columns of silica gel H with dichloromethane-methanol (v:v = 80:1--15:1), and then separated with Sephadex LH-20 (methanol) to obtain compound **5** (4 mg). P~3~ was separated with Sephadex LH-20 (dichloromethane/methanol, 1:1, v/v) and Sephadex LH-20 (methanol), and then subjected to atmospheric pressure chromatographic column of silica gel H with dichloromethane ~2~-acetone- methanol (v:v:v = 50:25:1) to obtain compound **6** (30 mg). P~4~ was separated on a silica gel H column by MPLC, eluted with dichloromethane-methanol (v:v = 100:1--5:1), and then separated with Sephadex LH-20 (methanol) to obtain compound **7** (11 mg). P~5~ was separated on a silica gel H column by MPLC, eluted with dichloromethane-methanol (v:v = 20:1--1:1), and then separated with Sephadex LH-20 (methanol) to obtain compound **8** (5 mg). P~6~ was separated with Sephadex LH-20 (dichloromethane/methanol, 1:1, v/v) and Sephadex LH-20 (methanol) to obtain compound **2** (74 mg). P~7~ was subjected to atmospheric pressure chromatographic column of silica gel H with dichloromethane-acetone-MeOH (v:v:v = 1:1:0.1--1:1:0.2) and then separated with Sephadex LH-20 (MeOH) to obtain compound **9** (39 mg).

The 90% ethanol part was separated by MPLC that was filled with silica gel H, eluted with petroleum ether-ethyl acetate (100:1--2:1, v/v) and dichloromethane- methanol (50:1--5:1, v/v) to obtain S~1~--S~5~. S~1~ was subjected to atmospheric pressure chromatographic column of silica gel H with petroleum ether-ethyl acetate-acetone (v:v:v = 100:1:1--2:1:1) and petroleum ether-ethyl acetate (v:v = 100:1--5:1) to obtain compound **10** (86 mg). S~2~ was subjected to decompressed chromatographic column of silica gel H with petroleum ether-ethyl acetate (v:v = 50:1--5:1), and then subjected to atmospheric pressure chromatographic column of silica gel H with petroleum ether- dichloromethane (v:v = 1:1--0:1) and petroleum ether-ethyl acetate (v:v = 20:1) to obtain compound **11** (25 mg). S~3~ was subjected to atmospheric pressure chromatographic column of silica gel H with petroleum ether- dichloromethane (v:v = 2:1--0:1) and dichloromethane-methanol (v:v = 20:3--10:1) to merge the same components based on TLC analysis. This part was then subjected to atmospheric pressure chromatographic column of silica gel H with petroleum ether-ethyl acetate (v:v = 20:3) to obtain compound **12** (45 mg). S~4~ was recrystallized to obtain white un-dissolved substance and yellow dissolved substance. The white un-dissolved substance was subjected to atmospheric pressure chromatographic column of silica gel H with dichloromethane-methanol (v:v = 50:1--3:1) to obtain compound **13** (39 mg). The yellow substance was separated with Sephadex LH-20 (dichloromethane/methanol, 1:1, v/v) to afford compound **14** (16 mg). S~5~ was recrystallized to obtain compound **15** (13 mg).

The coagulation activity of *Syringa oblata* Lindl flowers in vitro {#Sec8}
-------------------------------------------------------------------

Blood samples were drawn from Rabbit's Auricular vein without anaesthesia. The method was similar to our previous research \[[@CR12]\]. APTT, PT,TT and FIB were determined.

For all the tests mentioned above, blank solvent (dimethyl sulphoxide: Tween 80: normal saline = 2:1:17) was used as negative control, while the drugs of breviscapine (13.3 mg/mL) and Yunnan baiyao (5 mg/mL) used in the clinics were used as positive control. All the samples were dissolved in blank solvent. The concentrations of compounds were 5 mg/mL and all the extract samples were 15 mg/mL. PT, APTT, TT and FIB tests were conducted with Semi-Automated Coagulation Analyzer (CPC Diagnostics Pvt. Ltd, India).

Statistical analysis {#Sec9}
--------------------

The results of coagulation activity were expressed as mean ± standard deviation. The data analysis was performed by SPSS19.0 software with single factor analysis of variance (ANOVA One-Way) to determine the significant difference. The difference between groups with *P *\< 0.05 and *P *\< 0.001 were regarded as significant and highly significant, respectively. Results were shown in Table [1](#Tab1){ref-type="table"}.Table 1The effects of *S. oblata* extract and compounds on APTT, PT, TT, and FIB in vitro ($\documentclass[12pt]{minimal}
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                \begin{document}$$\bar{x} \pm s$$\end{document}$)GroupsPT(s)APTT(s)TT(s)FIB(g/L)Blank11.58 ± 0.2620.03 ± 0.2417.47 ± 0.363.16 ± 0.035Breviscapine14.90 ± 0.23\*\*\*23.68 ± 0.38\*\*\*20.05 ± 0.19\*\*\*2.97 ± 0.044\*\*Yunnan Baiyao10.65 ± 0.38\*\*\*11.35 ± 0.94\*\*\*12.68 ± 0.13\*\*\*5.00 ± 0.14\*\*\*Water part10.58 ± 0.22\*\*\*15.43 ± 0.22\*\*\*^&&&^16.43 ± 0.51\*\*\*^&&&^3.68 ± 0.087\*\*\*^&&&^20% ethanol part11.83 ± 0.358.8 ± 0.32\*\*\*^&&&^16.43 ± 0.26\*\*\*^&&&^3.50 ± 0.11\*\*\*^&&&^40% ethanol part12.35 ± 0.37\*\*\*^\#\#\#^14.53 ± 0.66\*\*\*^&&&^16.45 ± 0.10\*\*\*^&&&^4.51 ± 0.077\*\*\*^&&&^60% ethanol partNTNTNTNT90% ethanol part12.03 ± 0.28\*\*^\#\#\#^18.85 ± 0.26\*\*^&&&^16.75 ± 0.30\*\*^&&&^4.00 ± 0.062\*\*\*^&&&^So.TE12.63 ± 0.30\*\*\*^\#\#\#^14.58 ± 0.19\*\*\*^&&&^15.95 ± 0.21\*\*\*^&&&^3.78 ± 0.10\*\*\*^&&&^Lauric acid10.85 ± 0.26\*\*\*18.35 ± 0.26\*\*\*^&&&^15.57 ± 0.34\*\*\*^&&&^3.95 ± 0.033\*\*\*^&&&^Dictamnoside A11.50 ± 0.2619.82 ± 0.5913.93 ± 0.78\*\*\*^&&&^3.12 ± 0.050Kaempferol-rutinose10.55 ± 0.21^\*\*\*^17.45 ± 0.25\*\*\*^&&&^16.47 ± 0.29\*\*\*^&&&^3.22 ± 0.24Results were expressed as mean ± SD, *n *= 4, *NT*: not detectedCompared with blank: \*\*\* *P *\< 0.001; 0.001 \< \*\* *P *\< 0.01Compared with breviscapine: ^\#\#\#^ *P *\< 0.001Compared with Yunnan Baiyao: ^&&&^ *P *\< 0.001

Results {#Sec10}
=======

Chemical constituents in *S. oblate* flowers {#Sec11}
--------------------------------------------

Fifteen known compounds (**1**--**15**) were isolated and identified from *S. oblata* flowers. The structures of compounds were shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Structures of compound **1**--**15**

### Compound 1 {#FPar1}

Yellow power. The molecular formula was C~15~H~10~O~7~. EI-MS *m/z*: 302\[M\]^+^. ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ*: 12.49 (1H, s, 5-OH), 7.67 (1H, s, H-2′), 7. 55 (1H, d, *J *= 8.0 Hz, H-6′), 6.89 (1H, d, *J *= 8.0 Hz, H-5′), 6.40 (1H, s, H-8), 6.18 (1H, s, H-6); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ*: 146.74 (C-2), 135.66 (C-3), 175.77 (C-4), 156.09 (C-5), 98.15 (C-6), 163.95 (C-7), 93.29 (C-8), 160.65 (C-9), 102.90 (C-10), 121.90 (C-1′), 115,55 (C-2′), 145.01 (C-3′), 147.66 (C-4′), 115.01 (C-5′), 119.90 (C-6′). The above spectral data were basically consistent with those reported previously \[[@CR13]\] and thus, compound **1** was identified as quercetin.

### Compound 2 {#FPar2}

A yellow, needle-shaped crystal. Its molecular formula was C~27~H~30~O~15~. EI-MS *m/z*: 594 \[M\]^+^. ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ*: 12.57 (1H, s, 5-OH), 10.86 (1H, s, 7-OH), 10.14 (1H, s, 4′-OH), 8.00 (2H, d, *J *= 12.0 Hz, H-2′, 6′), 6.89 (2H, d, *J *= 8.0 Hz, H-3′, 5′), 6.42 (1H, d, *J *= 4.0 Hz, H-8), 6.21 (1H, d, *J *= 4.0 Hz, H-6), 5.32 (1H, d, *J *= 8.0 Hz, H-1′′), 4.44 (1H, brs, H-1′′′); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ*: 156.63 (C-2), 133.26 (C-3), 177.43 (C-4), 161.24 (C-5), 98.76 (C-6), 164.14 (C-7), 93.79 (C-8), 156.90 (C-9), 104.04 (C-10), 120.93 (C-1′), 130.93 (C-2′, 6′), 159.93 (C-4′), 115.14 (C-3′, 5′), 101.36 (C-1′′), 74.21 (C-2′′), 76.39 (C-3′′), 69.96 (C-4′′), 75.78 (C-5′′), 66.92 (C-6′′), 100.81 (C-1′′′), 70.39 (C-2′′′), 70.63 (C-3′′′), 71.85 (C-4′′′), 68.29 (C-5′′′), 17.77 (C-6′′′). The above data were basically consistent with those reported in the Ref. \[[@CR14]\]. Thus, compound **2** was identified as kaempferol-3-*O*-*α*-[l]{.smallcaps}-rhamnosyl-(1 → 6)-*β*-[d]{.smallcaps}-glucoside (kaempferol- rutinose).

### Compound 3 {#FPar3}

A white powder. The molecular formula was C~8~H~10~O~2~. EI-MS *m/z*: 138 \[M\]^+^. ^1^H-NMR (C~5~D~5~N, 400 MHz) *δ*: 7.33 (2H, d, *J *= 8.0 Hz, H-2, 6), 7.18 (2H, d, *J *= 8.0 Hz, H-3, 5), 4.11 (2H, d, *J *= 12.0 Hz, H-8), 3.05 (2H, t, *J *= 7.0 Hz, H-7); ^13^C-NMR (C~5~D~5~N, 100 MHz) *δ*: 130.59 (C-1), 130.54 (C-2, 6), 116.07 (C-3, 5), 157.17 (C-4), 39.58 (C-7), 63.86 (C-8). The above data were basically consistent with those reported in the Ref. \[[@CR15]\]. Thus, compound **3** was identified as 4-Hydroxyphenethyl alcohol.

### Compound 4 {#FPar4}

A white powder. The molecular formula was C~8~H~8~O~4~. EI-MS *m/z*: 168 \[M\]^+^. ^1^H-NMR (C~5~D~5~N, 400 MHz) *δ*: 8.19 (1H, dd, *J *= 8.0 Hz, 4.0 Hz, H-6), 8.09 (1H, d, *J *= 4.0 Hz, H-2), 7.32 (1H, d, *J *= 8.0 Hz, H-5), 3.74 (3H, s, 3-OCH~3~); ^13^C-NMR (C~5~D~5~N, 100 MHz) *δ*: 123.34 (C-1), 116.03 (C-2), 148.15 (C-3), 152.58 (C-4), 113.61 (C-5), 124.75 (C-6), 168.98 (C-7), 5.58 (C-8). The above data were basically consistent with those reported in the Ref. \[[@CR16]\]. Thus, compound **4** was identified as vanillic acid.

### Compound 5 {#FPar5}

This compound was a yellow-brown, needle-shaped crystal. The molecular formula was determined to be C~9~H~8~O~4~. EI-MS *m/z*: 180 \[M\]^+^. ^1^H-NMR (DMSO-*d*~6~, 400 MHz) *δ*: 7.42 (1H, d, *J *= 16.0 Hz, H-7), 7.01 (1H, s, H-2), 6.96 (1H, dd, *J *= 4.0, 8.0 Hz H-6), 6.76 (1H, d, *J *= 8.0 Hz, H-5), 6.18 (1H, d, *J *= 16.0 Hz, H-8); ^13^C-NMR (DMSO-*d*~6~, 100 MHz) *δ*: 125.72 (C-1), 114.60 (C-2), 144.34 (C-3), 148.09 (C-4), 115.36 (C-5), 115.74 (C-6), 145.55 (C-7), 121.04 (C-8), 168.00 (9-COOH). The above data were basically consistent with those reported in the Ref. \[[@CR17]\]. Thus, the compound **5** was identified as caffeic acid.

### Compound 6 {#FPar6}

A white powder. The molecular formula was C~17~H~24~O~8~. EI-MS *m/z*: 566 \[M\]^+^. ^1^H-NMR (400 MHz, C~5~D~5~N) *δ*: 6.60 (2H, s, H-3, 5), 6.03 (1H, m, H-*β*), 5.11 (2H, m, H-*γ*), 3.74 (6H, s, 2 × OCH~3~), 3.92--4.38 (6H, m, H-2′--6′), 3.34 (2H, d, *J *= 8.0 Hz, H-*α*); ^13^C-NMR (100 MHz, C~5~D~5~N) *δ*: 153.67 (C-2, 6), 137.82 (C-*β*), 136.26 (C-1), 134.45 (C-4), 115.87 (C-*γ*), 107.13 (C-3, 5), 105.02 (C-1′), 75.98 (C-2′), 78.58 (C-3′), 71.51 (C-4′), 78.28 (C-5′), 62.53 (C-6′), 56.46 (2 × OCH~3~), 40.44 (C-*α*). The above data were basically consistent with those reported in the Ref. \[[@CR18]\]. Thus, the compound **6** was identified as dictamnoside A.

### Compound 7 {#FPar7}

A yellow powder. The molecular formula was C~24~H~30~O~13~. EI-MS *m/z*: 526 \[M\]^+^. ^1^H-NMR (400 MHz, C~5~D~5~N) *δ*: 7.52 (1H, s, H-3), 6.65 (1H, s, H-5′′), 6.63 (1H, d, *J *= 1.5 Hz, H-2′′), 6.49 (1H, dd, *J *= 1.5 Hz, 8.5 Hz, H-6′′), 4.18 (2H, m, 2 × H-α), 3.02 (1H, m, H-5), 2.72 (2H, t, *J *= 6.5 Hz 2 × H-β), 2.07 (1H, q, H-9), 4.56 (1H, d, *J *= 8.0 Hz, H-1′), 1.41 (3H, d, *J *= 4.0 Hz, 10-Me); ^13^C-NMR (100 MHz, C~5~D~5~N) *δ*: 94.84 (C-1), 152.92 (C-3), 107.77 (C-4), 26.82 (C-5), 33.53 (C-6), 171.67 (C-7), 73.49 (C-8), 21.26 (C-10), 166.63 (C-11), 99.23 (C-1′), 73.20 (C-2′), 77.34 (C-3′), 70.16 (C-4′), 76.57 (C-5′), 61.38(C-6′), 128.75 (C-1′′), 116.21 (C-2′′), 145.12 (C-3′′), 143.76 (C-4′′), 115.55 (C-5′′), 119.62 (C-6′′), 64.93 (C-*α*), 33.88 (C-*β*). The above data were basically consistent with those reported in the Ref. \[[@CR19]\]. Thus, the compound **7** was identified as Lilacoside.

### Compound 8 {#FPar8}

A yellow powder. The molecular formula was C~21~H~20~O~12~. EI-MS *m/z*: 465 \[M\]^+^. ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ*: 12.65 (1H, s,5-OH), 7.59 (1H, d, *J *= 4.0 Hz, H-6′), 7.57 (1H, d, *J *= 4.0 Hz, H-2′), 6.85 (1H, d, *J *= 8.0 Hz, H-5′), 6.39 (1H, s, H-8), 6.20 (1H, d, *J *= 4.0 Hz, H-6), 5.46 (1H, d, *J* = 8.0 Hz, Glc-H-1′′), 3.17--3.24 (5H, m, Rha-H-2″--6″); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ*: 156.11 (C-2), 133.30 (C-3), 177.36 (C-4), 161.18 (C-5), 98.63(C-6), 164.21(C-7), 93.45(C-8), 156.28 (C-9), 103.78 (C-10), 121.52 (C-1′), 115.15 (C-2′), 144.75(C-3′), 148.41(C-4′), 116.16(C-5′), 121.11(C-6′), Glc: 100.92(C-1″), 74.06(C-2″), 77.46(C-3″), 69.92(C-4″), 76.48 (C-5″), 60.95 (C-6″). The above data were basically consistent with those reported in the Ref. \[[@CR20]\]. Thus, the compound **8** was identified as quercetin-3-*O*-*β*-[d]{.smallcaps}-glucoside.

### Compound 9 {#FPar9}

Was a yellow powder. The molecular formula was C~27~H~30~O~16~. EI-MS *m/z*: 610 \[M\]^+^. ^1^H-NMR (400 MHz, DMSO-*d*~6~) *δ*: 12.60 (1H, s, 5-OH), 10.84 (1H, s, 7-OH), 9.68 (1H, s, 4′-OH), 9.19 (1H, s, 3′-OH), 7.55 (2H, d, *J *= 8.0 Hz, H-2′, 6′), 6.85 (1H, d, *J *= 8.0 Hz, H-5′), 6.39 (1H, d, *J *= 4.0 Hz, H-8), 6.20 (1H, d, *J *= 4.0 Hz, H-6), 5.35 (1H, d, *J *= 4.0 Hz, H-1′′), 4.38 (1H, brs, H-1′′′); ^13^C-NMR (100 MHz, DMSO-*d*~6~) *δ*: 156.42 (C-2), 133.30 (C-3), 177.37 (C-4), 161.23 (C-5), 98.68 (C-6), 164.07 (C-7), 93.59 (C-8), 156.61 (C-9), 103.98 (C-10), 121.18 (C-1′), 115.23 (C-2′), 144.76 (C-3′), 148.42 (C-4′), 116.26 (C-5′), 121.59 (C-6′), 101.17 (C-1′′), 74.08 (C-2′′), 76.44 (C-3′′), 70.00 (C-4′′), 75.91 (C-5′′), 67.01 (C-6′′), 100.76 (C-1′′′), 70.38 (C-2′′′), 70.56 (C-3′′′), 71.84 (C-4′′′), 68.26 (C-5′′′), 17.77 (C-6′′′). The above data were basically consistent with those reported in the Ref. \[[@CR21]\]. Thus, the compound **9** was identified as rutin.

### Compound 10 {#FPar10}

A white solid. The molecular formula was C~16~H~32~O~2~. EI-MS *m/z*: 256 \[M\]^+^. ^1^H-NMR (CDCl~3~, 400 MHz) *δ*: 0.88 (3H, t, *J *= 9.0 Hz, H-16), 1.23--1.29 (24H, m, H-4--15), 1.61 (2H, m, H-3), 2.34 (2H, t, *J *= 7.5 Hz, H-2); ^13^C-NMR(CDCl~3~, 100 MHz) *δ*: 179.3 (--COOH), 34.23 (C-2), 24.83 (C-3), 29.21--29.85 (C-4--13), 32.08 (C-14), 22.85 (C-15), 14.27 (C-16). The above data were basically consistent with those reported in the Ref. \[[@CR22]\]. Thus, the compound **10** was identified as palmitic acid.

### Compound 11 {#FPar11}

A white solid. The molecular formula was C~12~H~24~O~2~. EI-MS *m/z*: 200 \[M\]^+^. ^1^H-NMR (CDCl~3~, 400 MHz) *δ*: 0.87 (3H, t, *J *= 7.0 Hz, H-12), 1.26 (16H, m, H-4--11), 1.80 (2H, m, H-3), 2.52 (2H, t, *J *= 8.0 Hz, H-2); ^13^C-NMR (CDCl~3~, 100 MHz) *δ*: 175.9(-COOH), 34.89 (C-2), 25.67 (C-3), 29.63--29.99 (C-4--9), 32.14 (C-10), 22.96 (C-11), 14.29 (C-12). The above data were basically consistent with those reported in the Ref. \[[@CR23]\]. Thus, the compound **11** was identified as lauric acid.

### Compound 12 {#FPar12}

A white powder. The molecular formula was C~30~H~48~O~3~. EI-MS *m/z*: 456 \[M\]^+^. ^1^H-NMR (C~5~D~5~N, 400 MHz) *δ*: 5.50 (1H, brs, H-12), 3.45 (1H, dd, *J *= 8.0 Hz, 4.0 Hz, H-3), 3.32 (1H, dd, *J *= 4.0 Hz, 4.0 Hz, H-18), 1.28 (3H, s, H-27), 1.24 (3H, s, H-25), 1.02 (3H, s, H-30), 1.01 (3H, s, H-29), 0.95 (3H, s, H-23), 0.89 (3H, s, H-26); ^13^C-NMR (C~5~D~5~N, 100 MHz) *δ*: 38.93 (C-1), 28.09 (C-2), 78.06 (C-3), 39.38 (C-4), 55.80 (C-5), 18.79 (C-6), 39.74 (C-8), 48.11 (C-9), 37.37 (C-10), 23.82 (C-11), 122.54 (C-12), 144.81 (C-13), 42.16 (C-14), 28.31 (C-15), 23.69 (C-16), 46.47 (C-17), 42.00 (C-18), 346.66 (C-19), 30.96 (C-20), 4.21 (C-21), 33.18 (C-22), 28.78 (C-23), 16.55 (C-24), 15.55 (C-25), 17.43 (C-26), 26.17 (C-27), 180.16 (C-28), 233.27 (C-7, 29), 3.76 (C-30). The above data were basically consistent with those reported in the Ref. \[[@CR16]\]. Thus, the compound **12** was identified as oleanolic acid.

### Compound 13 {#FPar13}

Was a white powder. The molecular formula was C~30~H~48~O~3~. EI-MS *m/z*: 456 \[M\]^+^. ^1^H-NMR (C~5~D~5~N, 400 MHz) *δ*: 5.49 (1H, s, H-12), 3.46 (1H, dd, *J *= 8.0 Hz, 8.0 Hz, H-3), 2.65 (1H, d, *J *= 8.0 Hz, H-18), 1.25 (3H, s, H-27), 1.23 (3H, s, H-26), 1.05 (3H, s, H-23), 0.96 (3H, d, *J *= 8.0 Hz, H-29), 0.88 (3H, s, H-24), 1.01 (3H, d, *J *= 8.0 Hz, H-30), 1.02 (3H, s, H-25); ^13^C-NMR (C~5~D~5~N, 100 MHz) *δ*: 37.43 (C-1), 28.11 (C-2), 78.09 (C-3), 39.06 (C-4), 55.80 (C-5), 18.77 (C-6), 33.56 (C-7), 39.94 (C-8), 48.02 (C-9), 39.47 (C-10), 23.90 (C-11), 125.63 (C-12), 139.24 (C-13), 42.48 (C-14), 28.80 (C-15), 24.89 (C-16), 48.02 (C-17), 53.52 (C-18), 39.39 (C-19), 39.37 (C-20), 31.06 (C-21), 37.26 (C-22), 28.67 (C-23), 15.67 (C-24), 16.58 (C-25), 17.52 (C-26), 23.61 (C-27), 179.88 (C-28), 17.43 (C-29), 21.42 (C-30). The above data were basically consistent with those reported in the Ref. \[[@CR16]\]. Thus, the compound **13** was identified as ursolic acid.

### Compound 14 {#FPar14}

A yellow powder. The molecular formula was C~15~H~12~O~5~ EI-MS *m/z*: 272 \[M\]^+^. ^1^H-NMR (C~5~D~5~N, 400 MHz) *δ*: 12.83 (1H, s, 5-OH), 7.55 (2H, d, *J *= 8.0 Hz, H-2′, 6′), 7.22 (2H, d, *J *= 8.0 Hz H-3′, 5′), 6.49 (1H, d, *J *= 4.0 Hz, H-8), 6.18 (1H, s,H-6), 5.51 (1H, dd, *J *= 4.0 Hz, 4.0 Hz, H-2), 5.32 (2H, s, H-6, 8), 3.33 (1H, dd, *J *= 12.0 Hz, 12.0 Hz, H-3a), 2.90 (1H, dd, *J *= 0 Hz, 4.0 Hz, H-3b); ^13^C-NMR (C~5~D~5~N, 100 MHz) *δ*: 79.65 (C-2), 43.29 (C-3), 196.53 (C-4), 165.16 (C-5), 97.22 (C-6), 168.56 (C-7), 96.11 (C-8), 164.03 (C-9), 102.87 (C-10), 129.76 (C-1′), 128.86 (C-2′, 6′), 116.42 (C-3′, 5′), 159.53 (C-4′). The above data were basically consistent with those reported in the Ref. \[[@CR24]\]. Thus, the compound **14** was identified as naringenin.

### Compound 15 {#FPar15}

A white powder. The molecular formula was C~35~H~60~O~6~. EI-MS *m/z*: 578\[M\]^+^. It was compared with reference substance of *β*-daucosterol, no difference was seen between them in term of the TLC detection. Thus compound **15** was identified as *β*-daucosterol.

Coagulation time test in vitro {#Sec12}
------------------------------

In Fig. [2](#Fig2){ref-type="fig"}, water part, lauric acid and kaempferol-rutinose could significantly shorten PT (*P *\< 0.001) compared with the blank group. The 40% ethanol part, 90% ethanol part and So.TE had significant anticoagulant activity (*P *\< 0.001 and 0.001 \< *P*\<0.01) compared with the blank group. The effects of water part, lauric acid and kaempferol-rutinose were not different with that of Yunnan Baiyao.Fig. 2The effects of *S. oblata* extract and compounds on PT in vitro

In the Fig. [3](#Fig3){ref-type="fig"}, all the samples except 60% ethanol part and dictamnoside A could significantly shorten TT (*P *\< 0.001 and 0.001 \< *P* \< 0.01) compared with the blank group. The procoagulant activity of 20% ethanol part was the best one (*P *\< 0.001) compared with the Yunnan Baiyao.Fig. 3The effects of *S. oblata* extract and compounds on APTT in vitro

In Fig. [4](#Fig4){ref-type="fig"}, water part, 20% ethanol part, 40% ethanol part, 90% ethanol part, So, TE, lauric acid and kaempferol-rutinose could significantly shorten APTT (*P *\< 0.001) compared with the blank group. Water part, 20% ethanol part, 40% ethanol part, 90% ethanol part, So.TE, lauric acid and kaempferol-rutinose had procoagulant activity compared with the Yunnan Baiyao, and 20% ethanol part had a higher activity than that of Yunnan Baiyao, while the others were not better than that of Yunnan Baiyao.Fig. 4The effects of *S. oblata* extract and compounds on TT in vitro

In Fig. [5](#Fig5){ref-type="fig"}, water part, 20% ethanol part, 40% ethanol part, 90% ethanol part, So.TE and lauric acid all could significantly increase the FIB content (*P *\< 0.001) compared with the blank group. The procoagulant activity of the positive control was the best one (*P *\< 0.001) compared with the Yunnan Baiyao.Fig. 5The effects of *S. oblata* extract and compounds on FIB in vitro

Discussion {#Sec13}
==========

Sun et al. \[[@CR25]\] found that the volatile compounds in fresh flowers of *S. oblate* during different flowering periods were different. Dong et al. \[[@CR6]\] isolated 8 compounds from the alabastrum of *S. oblate*, and they were identified as syringopicrogenin-B, oleandic acid, ursolic acid, lupanic acid, luprol, *p*-hydroxy phenylpropanol, *p*-hydroxy phenylethanol and *β*-sitosterol. Triterpenic acids were the main components. In this study, fifteen known compounds were isolated from *S. oblata* flowers. They were identified as quercetin (**1)**, kaempferol-3-*O*-*α*-[l]{.smallcaps}-rhamnosyl-(1 → 6)-*β*-[d]{.smallcaps}-glucoside (**2**, kaempferol-rutinose), 4-Hydroxyphenethyl alcohol (**3**), vanillic acid (**4**), caffeic acid (**5**), dictamnoside A (**6**), Lilacoside (**7**), quercetin-3-O-*β*-D-glucoside (**8**), rutin (**9**), palmitic acid (**10**), lauric acid (**11**), oleanolic acid (**12**), ursolic acid (**13**), naringenin (**14**), and *β*-daucosterol (**15**). Flavonoids, organic acids and Triterpenic acids were the main components.

The previous studies on *S. oblate* flowers were mainly focused on the volatile components and its traditional pharmacological activity. In the present study we found that the *S. oblate* flowers had a significant procoagulant activity for the first time. Our researches showed that water part, lauric acid and kaempferol-rutinose all displayed a significant procoagulant activity, and that the procoagulant activity of water part, lauric acid, and kaempferol-rutinose were not better than that of Yunnan Baiyao, which was used as the positive control.

Conclusions {#Sec14}
===========

In the present study, fifteen compounds were isolated and identified from *S. oblate* flowers, including triterpenic acids, fatty acids and flavonone glycosides etc. Water extract of *S. oblate* flowers, lauric acid and kaempferol-rutinose possessed the procoagulant activity.

APTT

:   activated partial thromboplastin time

PT

:   prothrombin time

TT

:   thrombin time

FIB

:   fibrinogen

So.TE

:   total extract of *S. oblata* flowers

Water part

:   water extract of *S. oblata* flowers

20% ethanol part

:   20% ethanol extract of *S. oblata* flowers

40% ethanol part

:   40% ethanol extract of *S. oblata* flowers

60% ethanol part

:   60% ethanol extract of *S. oblata* flowers

90% ethanol part

:   90% ethanol extract of *S. oblata* flowers
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